Abiopharma

Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update

(91% Neutral) TRON INC. (TRON) Reports Q2 2026 Financial Results

Abeona Therapeutics® Announces Activation of Childrens Hospital of Philadelphia as a New Qualified Treatment Center forZEVASKYN®

(99% Neutral) UBER TECHNOLOGIES, INC (UBER) Announces New Board Appointment

(99% Neutral) PURECYCLE TECHNOLOGIES, INC. (PCTTW) Reports Q2 2026 Financial Results

Evolus - Evolus Announces Commercial Launch ofEstyme® Injectable Hyaluronic Acid Gels in Europe

(99% Neutral) LM FUNDING AMERICA, INC. (LMFA) Announces Business Combination

TRON INC. REPORTS FIRST QUARTER 2026 RESULTS

Global Payments Announces Exclusive Agreement with CKE Restaurants

Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting

Astrotech Corporation Receives ECAC/EU G1 Certification of Trace Detection in Aviation Security

ReNew Announces Date and Conference Call Details for Fourth Quarter Earnings (Q4 FY26), Fiscal Year 2026 Results

Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle

LM Funding America Announces April 2026 Production and Operational Update

Disc Medicine to Participate in Upcoming Investor Conferences